Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Nicotine Patches to Reduce Hand-Foot Syndrome Associated With Capecitabine Chemotherapy in Patients With Metastatic Breast Cancer

NCT00751101 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00751101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00751101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Nicotine Patches to Reduce Hand-Foot Syndrome Associated With Capecitabine Chemotherapy in Patients With Metastatic Breast Cancer
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Terminated
Start date
August 20, 2007
Completion date
March 24, 2018
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, chemotherapeutic agent toxicity, palmar-plantar erythrodysesthesia